These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12869408)
1. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Tsao AS; McDonnell T; Lam S; Putnam JB; Bekele N; Hong WK; Kurie JM Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):660-4. PubMed ID: 12869408 [TBL] [Abstract][Full Text] [Related]
2. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744 [TBL] [Abstract][Full Text] [Related]
3. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Balsara BR; Pei J; Mitsuuchi Y; Page R; Klein-Szanto A; Wang H; Unger M; Testa JR Carcinogenesis; 2004 Nov; 25(11):2053-9. PubMed ID: 15240509 [TBL] [Abstract][Full Text] [Related]
4. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin. Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Rusch V; Klimstra D; Linkov I; Dmitrovsky E Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells. Lee HY Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408 [TBL] [Abstract][Full Text] [Related]
9. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735 [TBL] [Abstract][Full Text] [Related]
10. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
12. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064 [TBL] [Abstract][Full Text] [Related]
13. Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium. Wu X; Xiao Z; Chen Z; Li C; Li J; Feng X; Yi H; Liang S; Chen P Pathol Int; 2004 Oct; 54(10):765-73. PubMed ID: 15482566 [TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Chang YS; Chung JH; Shin DH; Chung KY; Kim YS; Chang J; Kim SK; Kim SK Yonsei Med J; 2004 Jun; 45(3):435-42. PubMed ID: 15227730 [TBL] [Abstract][Full Text] [Related]
16. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers. Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170 [TBL] [Abstract][Full Text] [Related]
17. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038 [TBL] [Abstract][Full Text] [Related]
20. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation. Hilbe W; Auberger J; Dirnhofer S; Schmid T; Erdel M; Duba HC Oncol Rep; 2006 May; 15(5):1233-40. PubMed ID: 16596192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]